These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2507135)

  • 41. Treatment of hamster pancreatic cancer with alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis.
    Marx M; Townsend CM; Barranco SC; Glass EJ; Thompson JC
    J Natl Cancer Inst; 1987 Sep; 79(3):543-8. PubMed ID: 3114535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment with alpha-difluoromethylornithine plus a spermidine analog leads to spermine depletion and growth inhibition in cultured L1210 leukemia cells.
    Casero RA; Bergeron RJ; Porter CW
    J Cell Physiol; 1984 Dec; 121(3):476-82. PubMed ID: 6438117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amelioration of thrombocytopenia with concomitant ornithine in sarcoma-bearing rats receiving high dose difluoromethylornithine.
    Grossie VB; Ota DM; Ajani JA; Nishioka K
    Invest New Drugs; 1991 Nov; 9(4):321-6. PubMed ID: 1804805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of cyclosporin A and alpha-difluoromethylornithine on the growth of hamster pancreatic cancer in vitro.
    Saydjari R; Townsend CM; Barranco SC; James E; Thompson JC
    J Natl Cancer Inst; 1986 Nov; 77(5):1087-92. PubMed ID: 3022056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced cytocidal efficacy for adriamycin in cultured human carcinoma cells depleted of polyamines by difluoromethylornithine treatment.
    Seidenfeld J; Komar KA; Naujokas MF; Block AL
    Cancer Res; 1986 Mar; 46(3):1155-9. PubMed ID: 3080235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced cytotoxicity and DNA damage by alpha-difluoromethylornithine in L1210 leukemia cells.
    Cavanaugh PF; Pavelic ZP; Porter CW
    Cancer Res; 1984 Sep; 44(9):3856-61. PubMed ID: 6430555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polyamine depletion-mediated effects on murine odontogenesis are dependent on tooth developmental stage and culture conditions.
    Gritli-Linde A; Ruch JV; Linde A
    Int J Dev Biol; 1995 Apr; 39(2):383-93. PubMed ID: 7669549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine.
    Luk GD; Abeloff MD; McCann PP; Sjoerdsma A; Baylin SB
    Cancer Res; 1986 Apr; 46(4 Pt 1):1849-53. PubMed ID: 3004708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary polyamine levels in cancer patients treated with D,L-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis.
    Horn Y; Spigel L; Marton LJ
    J Surg Oncol; 1989 Jul; 41(3):177-82. PubMed ID: 2501593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase I trial and pharmacokinetic study of intravenous and oral alpha-difluoromethylornithine.
    Griffin CA; Slavik M; Chien SC; Hermann J; Thompson G; Blanc O; Luk GD; Baylin SB; Abeloff MD
    Invest New Drugs; 1987; 5(2):177-86. PubMed ID: 3115911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polyamine-directed preferential nutritional repletion of normal tissues in tumor-bearing hosts.
    Nishioka K; Grossie VB; Ajani JA; Patenia D; Chang TH; Ota DM
    Int J Cancer; 1988 Nov; 42(5):744-7. PubMed ID: 3141298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modification of radiation-induced brain injury by alpha-difluoromethylornithine.
    Gobbel GT; Marton LJ; Lamborn K; Seilhan TM; Fike JR
    Radiat Res; 1991 Dec; 128(3):306-15. PubMed ID: 1961928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase I-II clinical trial with alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis.
    Horn Y; Schechter PJ; Marton LJ
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1103-7. PubMed ID: 3115786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclosporine and alpha-difluoromethylornithine exhibit differential effects on colon and pancreatic cancer in vitro.
    Saydjari R; Townsend CM; Barranco SC; Thompson JC
    Invest New Drugs; 1987; 5(3):251-8. PubMed ID: 3117720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of alpha-difluoromethylornithine on the polyamine levels and proliferation in two transplantable tumours.
    Alison MR; Sarraf CE; Emons VE; Hill SA; Maghsoudloo M; Murphy GM
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(3):223-30. PubMed ID: 1926763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis.
    Abeloff MD; Slavik M; Luk GD; Griffin CA; Hermann J; Blanc O; Sjoerdsma A; Baylin SB
    J Clin Oncol; 1984 Feb; 2(2):124-30. PubMed ID: 6422008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase I study of alpha-difluoromethylornithine and methyl-GAG.
    Splinter TA; Romijn JC
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):61-7. PubMed ID: 3082642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia.
    Mitchell MF; Tortolero-Luna G; Lee JJ; Hittelman WN; Lotan R; Wharton JT; Hong WK; Nishioka K
    Clin Cancer Res; 1998 Feb; 4(2):303-10. PubMed ID: 9516915
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation between transglutaminase activity and polyamine levels in human neuroblastoma cells. Effect of retinoic acid and alpha-difluoromethylornithine.
    Melino G; Farrace MG; Ceru' MP; Piacentini M
    Exp Cell Res; 1988 Dec; 179(2):429-45. PubMed ID: 2903830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alterations in human circulating and bone marrow mononuclear cell polyamine levels in hematologic malignancies as a consequence of difluoromethylornithine administration.
    Maddox AM; Freireich EJ; Keating MJ; Frasier-Scott KF; Haddox MK
    Invest New Drugs; 1988 Jun; 6(2):125-34. PubMed ID: 3139580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.